Related references
Note: Only part of the references are listed.Proteomic Profiling for Metabolic Pathways Involved in Interactive Effects of Elevated Carbon Dioxide and Nitrogen on Leaf Growth in a Perennial Grass Species
Jingjin Yu et al.
JOURNAL OF PROTEOME RESEARCH (2019)
Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair M. Younossi et al.
CLINICS IN LIVER DISEASE (2018)
Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats
Xiaorui Yao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Quantitative proteomics identify an association between extracellular matrix degradation and immunopathology of genotype VII Newcastle disease virus in the spleen in chickens
Zenglei Hu et al.
JOURNAL OF PROTEOMICS (2018)
Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice
Chian-Jiun Liou et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Herbal Extracts and Natural Products in Alleviating Non-alcoholic Fatty Liver Disease via Activating Autophagy
Li Zhang et al.
FRONTIERS IN PHARMACOLOGY (2018)
Protective effects of oxymatrine against arsenic trioxideinduced liver injury
Li Li et al.
ONCOTARGET (2017)
Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high-fat diet
Gregory G. Martin et al.
JOURNAL OF LIPID RESEARCH (2017)
Differential Proteomic Analysis of Dimethylnitrosamine (DMN)-Induced Liver Fibrosis
Xiujie Liu et al.
PROTEOMICS (2017)
AMPK as a Therapeutic Target for Treating Metabolic Diseases
Emily A. Day et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1
Meiyuan Zhang et al.
SCIENTIFIC REPORTS (2017)
Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease
Takako Mukai et al.
FEBS OPEN BIO (2017)
Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1
Yinliang Zhang et al.
MOLECULAR METABOLISM (2017)
Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease
Qian Liu et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters
Enoch Cobbina et al.
DRUG METABOLISM REVIEWS (2017)
Non-alcoholic Fatty Liver Disease: A Clinical Update
Joseph M. Pappachan et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2017)
Treatment of nonalcoholic fatty liver disease: role of AMPK
Brennan K. Smith et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis
Charles P. Najt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease
Wei-Fan Hsu et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors
Thelma S. Angeles et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
Oxymatrine attenuates CCl4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-β1 signaling pathways
Hong-wei Zhao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome
Andrew E. Libby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis
Hong Xu et al.
JOURNAL OF ENDOCRINOLOGY (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Potential Signaling Pathways Involved in the Clinical Application of Oxymatrine
Mei-Li Lu et al.
PHYTOTHERAPY RESEARCH (2016)
Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
Shunquan Wu et al.
SCIENTIFIC REPORTS (2016)
Recent insights into the biological functions of liver fatty acid binding protein 1
GuQi Wang et al.
JOURNAL OF LIPID RESEARCH (2015)
Proteomic and genomic studies of non-alcoholic fatty liver disease - clues in the pathogenesis
Jun Wei Lim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1(Srebf1) and activation of peroxisome proliferator activated receptor alpha (Ppar alpha)
Li-juan Shi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease
James L. McManaman et al.
JOURNAL OF LIPID RESEARCH (2013)
Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation
Lijuan Shi et al.
MOLECULAR MEDICINE REPORTS (2013)
From fatty liver to fibrosis: A tale of second hit
Metin Basaranoglu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Direct interaction of Plin2 with lipids on the surface of lipid droplets: a live cell FRET analysis
Avery L. McIntosh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Fatty acid synthase and liver triglyceride metabolism: Housekeeper or messenger?
Anne P. L. Jensen-Urstad et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Expression of Perilipin and Adipophilin in Nonalcoholic Fatty Liver Disease; Relevance to Oxidative Injury and Hepatocyte Ballooning
Hideki Fujii et al.
Journal of Atherosclerosis and Thrombosis (2011)
SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism
Bhaskar Ponugoti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC-MS/MS
Richard D. Unwin et al.
NATURE PROTOCOLS (2010)
Hepatic phenotype of liver fatty acid binding protein gene-ablated mice
Gregory G. Martin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation
Aparna Purushotham et al.
CELL METABOLISM (2009)
Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice
Elizabeth P. Newberry et al.
HEPATOLOGY (2006)
Liver fatty acid-binding protein colocalizes with peroxisome proliferator activated receptor α and enhances ligand distribution to nuclei of living cells
H Huang et al.
BIOCHEMISTRY (2004)
Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors α- and γ-mediated gene expression via liver fatty acid binding protein:: A signaling path to the nucleus
C Wolfrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
